Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group

Eur J Cancer. 1992;28A(4-5):855-7. doi: 10.1016/0959-8049(92)90132-l.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nitrogen Mustard Compounds / adverse effects
  • Nitrogen Mustard Compounds / therapeutic use*
  • Sarcoma / drug therapy*
  • Soft Tissue Neoplasms / drug therapy*
  • Thrombocytopenia / chemically induced

Substances

  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • mitozolomide